en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianpt Portugueseru Russianes Spanish

The 4WHIM Trial

For People Living with WHIM Syndrome

No longer enrolling

About the 4WHIM Trial

The 4WHIM clinical research study is no longer enrolling. Results of this phase 3 study will determine if the investigational study drug, mavorixafor, helps people with WHIM syndrome by targeting the way the disease works and safely reduces bacterial infections and warts.

Learn More

Clinical Research

Considering a clinical trial? Learn more about clinical research studies so you can make an informed decision.

Learn More

Resources

Learn more about no-cost genetic testing, clinical trials and WHIM syndrome.

Learn More

Stay informed and follow the 4WHIM Trial

Enter your email address to receive updates about the 4WHIM Trial, WHIM syndrome, and X4 Pharmaceuticals news.

    I hereby authorize X4 Pharmaceuticals, together with any individuals or entities working for or on behalf of X4 Pharmaceuticals, to contact me by mail or email for marketing purposes, including to conduct market research or to obtain similar information from me, and to provide information to me about X4’s drug candidates, services, programs or other potential topics of interest. I understand that I may withdraw the above authorization and choose not to receive future information or updates from X4 Pharmaceuticals at any time by contacting X4 Pharmaceuticals at the following address: patientinfo@x4pharma.com or call 857-529-5779